OCT 14, 2016 11:14 AM PDT

T Cell Infusion Method Enhances Anti-Cancer Effect

WRITTEN BY: Kara Marker
Enhancing a cancer patient’s own T cells to reduce tumor growth is an up-and-coming cancer therapy that is being used to treat multiple types of tumor growth. A new study from the Medical University of South Carolina, in collaboration with Loyola University, offers a new way to insure that the enhanced T cells survived once they re-enter the body.
Credit: Medical University of South Carolina
Adoptive cell therapy (ACT) began as an immune-boosting cancer treatment as scientists began infusing autologous, melanoma-specific T cells obtained from the patient’s own supply of cells. After obtaining the cells, researchers genetically modify them with therapeutic receptors, activate them, and then stimulate them to proliferating before facilitating a therapeutic re-infusion back into the patient’s bloodstream. 

Unfortunately, rapid proliferation before reinfusion makes T cells increasingly prone to activation induced cell death (AICD), and the best results only occur when the transferred enhanced T cells survive. Fast-forward to this study and the authors’ current goals: how can they prevent AICD to enhance ACT’s effectiveness at targeting cancer, mainly melanoma? After extensive experimentation, they found that culturing the T cells in N-acetyl cysteine (NAC) before re-infusion protects them from AICD, making the immunotherapy increasingly effective and outcomes much more promising in a preclinical model of melanoma.

The collaborative effort led to the researchers seeing significant improvements in T cell persistence and overall outcomes when they added NAC to the in vitro T cell expansion culture. Apparently, NAC prevents increases in a DNA damage marker called yH2AX. Specifically, 40 percent of NAC-cultured T cells were detectable in tumors post-re-infusion as compared to only 1.2 percent of standard-culture T cells. 

"We were really surprised," said senior author of the recent Cancer Research study Christina Voelkel-Johnson, PhD, from the Medical University of South Carolina. "Given the harsh environment T cells encounter within tumors, we did not expect that the number of NAC-cultured T cells would be 33-fold higher than T cells not cultured in NAC." Plus, in mice models, they saw a significant delay of tumor growth in mice receiving T cell re-infusion after being cultured in NAC.

Their studies show that NAC culture reduces the level of reactive oxygen species (ROS), which reduces the amount of damage done to the DNA through an extensive molecular pathway of kinases, tumor proteins, and antibodies. When less DNA damage occurs in T cells, the body’s regulatory cells don’t have to make a choice between repair and cell death, reducing the overall rate of T cells destroyed because of DNA damage.

Next up: how does NAC culturing of T cells affect their phenotype? How does it work? In Voelkel-Johnson’s words: “There may be benefits to culturing T cells in NAC aside from generating AICD resistance that we haven't yet recognized."

More about melanoma:

Melanoma is a cancer that begins in the melanocytes. It’s less common than basal cell and squamous cell skin cancers, but it’s more dangerous because it is more likely to metastasize if not treated early. The American Cancer Society estimates that more than ten thousand people in the United States will die from melanoma in 2016.
 


Sources: Medical University of South Carolina, American Cancer Society
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 15, 2019
Immunology
SEP 15, 2019
Decipher the Clues with CRISPR
Scientists have created the first retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, which are key cells in the immune system. Researchers mapped the most...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Children and Adolescents
Myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS), is a disabling condition that affects every aspect of a person’s life. In the U. S.,...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
The Role of the Gut-Lung Axis in the Development of Tuberculosis
Observations of the human microbiota date back as far as the 1680s when Antonie van Leeuwenhoek noted significant differences in the types of bacteria from...
SEP 15, 2019
Cannabis Sciences
SEP 15, 2019
Can you be Allergic to Cannabis?
Pollen allergies are very common. As cannabis flowers produce, it is also possible to be allergic to cannabis. Here's what to look out for....
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Why does the flu virus thrive during winter?
If you’re one of the nearly 7 million people who suffered from influenza last season, you might be curious why the virus hits so much during winter m...
SEP 15, 2019
Cardiology
SEP 15, 2019
Better Sleep, Brought To You By Exercise
Regular difficulty falling or staying asleep, called chronic insomnia, is the most common sleep disorder among adults. In the search for better, more restf...
Loading Comments...